Author

Allan Covens

Observed name: A.L. Covens

Institutions: Sunnybrook Health Science Centre, University of Toronto, Sunnybrook Hospital, Sunnybrook Research Institute, Odette Cancer Centre

Observed institutions: Sunnybrook Health Science Centre, University of Toronto, Sunnybrook Hospital, Sunnybrook Research Institute, Odette Cancer Centre

OpenAlex ID: A5047192084

Results of a randomized phase III trial of letrozole alone versus paclitaxel and carboplatin followed by letrozole as initial treatment for patients with stage II-IV ovarian, fallopian tube, or primary peritoneal low-grade serous carcinoma (NRG-GY019, NCT04095364)

2026 · Amanda Fader, Austin Miller, et al. · Gynecologic Oncology · 4

Effect of fragmentation of surgery and adjuvant treatment in high-grade nonendometrioid endometrial cancer: a population-based cohort study

2024 · Andra Nica, Rinku Sutradhar, et al. · American Journal of Obstetrics and Gynecology · 4

The International Gynecologic Cancer Society Global Fellowship Program: advancing access to gynecologic oncology and surgical care worldwide

2026 · Parisa N. Fallah, Anisa Mburu, et al. · International Journal of Gynecological Cancer · 3

Patterns of care of gestational trophoblastic disease in Ontario: a population-based study

2026 · Genevieve Bouchard-Fortier, Zharmaine Ante, et al. · International Journal of Gynecological Cancer · 1

Postoperative Complications in Elderly Patients Undergoing Surgery for Ovarian Cancer: A NSQIP Analysis

2025 · Lina Salman, Allan Covens, et al. · Journal of Surgical Oncology · 1

Uptake of sentinel lymph node procedures in women with vulvar cancer over time in population-based study

2018 · T. Zigras, R. Kupets, et al. · Gynecologic Oncology · 1

Rates over time and regional variation of radical minimally invasive surgery for cervical cancer: A population-based study

2018 · K.A. Willows, R. Kupets, et al. · Gynecologic Oncology · 1

A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor

2026 · Elizabeth E. Hopp, Danielle Enserro, et al. · Gynecologic Oncology

RAINFOL-03 (ENGOT-EN-31/GOG-3128): A global, phase 3, open-label, randomized study of rinatabart sesutecan (Rina-S) vs investigator’s choice of chemotherapy in patients with endometrial cancer after platinum-based chemotherapy and programmed death-ligand 1 inhibition.

2026 · Antonio Gonzalez Martin, Elena Ioana Braicu, et al. · Journal of Clinical Oncology

Updates on the International Gynecologic Cancer Society (igcs) Global Fellowship Program

2025 · Parisa Fallah, Anisa Mburu, et al. · International Journal of Gynecological Cancer

The International Gynecologic Cancer Society (IGCS) Global Fellowship Program: Updates in advancing access to gynecologic oncology care globally

2025 · Parisa Fallah, Anisa Mburu, et al. · Gynecologic Oncology

Should we advocate for the continued availability of actinomycin D to remain an essential first-line treatment for low-risk gestational trophoblastic neoplasia?

2025 · Stephanie Gill, Brenna Swift, et al. · Gynecologic Oncology

Informing the gravid void: A population-based study of live birth rates after oncologic immunotherapy in reproductive age women.

2025 · Anouk Benseler, Lena Nguyen, et al. · Journal of Clinical Oncology

Works count: 13

Citation count: 15

H-index: 3

I10-index: